Close

Can-Fite BioPharma (CANF) Announces Submission of CF102 Phase 2 Protocol as NAFLD/NASH Treatment

Go back to Can-Fite BioPharma (CANF) Announces Submission of CF102 Phase 2 Protocol as NAFLD/NASH Treatment